内源性和外源性凋亡及细胞焦亡参与脓毒性休克患者B细胞亚群的选择性耗竭
该研究纳入32例脓毒性休克患者和10名健康志愿者,用流式细胞术检测B细胞亚群中Bcl-2、CD95、cleaved caspase-9/8及活化caspase-3/1的表达;另纳入23例脓毒性休克患者,体外测试caspase-3抑制剂Z-DEVD-FMK和caspase-1抑制剂VX-765对B细胞亚群耗竭的缓解作用。结果显示脓毒性休克患者IM B细胞Bcl-2降低、cleaved caspase-9升高,IM、naive、RM、AM B细胞CD95升高,IM、RM、AM B细胞cleaved caspase-8及活化caspase-3/1升高;IM B细胞活化caspase-1高于活化caspase-3,而AM B细胞活化caspase-1低于活化caspase-3。体外实验显示Z-DEVD-FMK和VX-765可减轻IM、AM、RM B细胞耗竭。作者认为脓毒性休克患者循环B细胞亚群的选择性减少可归因于内源性凋亡、外源性凋亡及细胞焦亡。
要点
- 32例脓毒性休克患者免疫抑制期IM B细胞Bcl-2降低、cleaved caspase-9升高,提示内源性凋亡参与IM B细胞耗竭。
- 脓毒性休克患者IM、naive、RM、AM B细胞CD95升高,IM、RM、AM B细胞cleaved caspase-8升高,提示外源性凋亡参与。
- IM、RM、AM B细胞活化caspase-3和caspase-1均升高;IM B细胞活化caspase-1高于活化caspase-3,AM B细胞活化caspase-1低于活化caspase-3。
- 体外实验中caspase-3抑制剂Z-DEVD-FMK和caspase-1抑制剂VX-765可减轻IM、AM、RM B细胞耗竭。
适用人群与场景
- 脓毒性休克患者(32例用于表达检测,另23例用于体外抑制实验),处于免疫抑制期;对照组为10名健康志愿者。
研究设计与关键结果
- 研究类型为病例对照研究加体外实验;脓毒性休克组32例,健康对照组10例,另纳入23例脓毒性休克患者进行体外抑制实验。
- 脓毒性休克患者IM B细胞Bcl-2水平降低、cleaved caspase-9水平升高。
- 脓毒性休克患者IM、naive、RM、AM B细胞CD95水平升高;IM、RM、AM B细胞cleaved caspase-8水平升高。
- 脓毒性休克患者IM、RM、AM B细胞活化caspase-3和活化caspase-1水平升高。
- 脓毒性休克患者IM B细胞活化caspase-1水平高于活化caspase-3;AM B细胞活化caspase-1水平低于活化caspase-3。
- 体外实验中Z-DEVD-FMK和VX-765可减轻IM、AM、RM B细胞耗竭。
证据类型、等级与局限
- 证据类型:病例对照研究加体外实验;原文未报告证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为脓毒性休克患者循环B细胞亚群的选择性减少可归因于内源性凋亡、外源性凋亡及细胞焦亡。
- 体外实验显示caspase-3抑制剂Z-DEVD-FMK和caspase-1抑制剂VX-765可减轻IM、AM、RM B细胞耗竭,原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The depletion of peripheral blood B cells is associated with immunosuppression and poor prognosis during sepsis, and selective depletion occurs when B cell subsets are specifically targeted. In this study, we examined the mechanisms underlying the selective depletion of B cell subsets in the immunosuppressive phase of septic shock patients. Thirty-two septic shock patients were recruited as a septic shock group and 10 healthy volunteers as a control group. The expression of Bcl-2, CD95, cleaved caspase-9/8, and activated caspase-3/1 in the B cell subsets were measured by flow cytometry. Another 23 septic shock patients were recruited to test the remission of caspase-3 (Z-DEVD-FMK) and caspase-1 (VX-765) inhibitors on B cell subset depletion in vitro . In septic shock patients, the Bcl-2 levels in immature/transitional (IM) B cells decreased and the levels of cleaved caspase-9 in IM B cells increased; the levels of CD95 in IM, naive, resting memory (RM), and activated memory (AM) B cells and the levels of cleaved caspase-8 in IM, RM, and AM B cells increased; the levels of activated caspase-3 and caspase-1 in IM, RM, and AM B cells increased. Activated caspase-1 levels in IM B cells were higher compared with activated caspase-3 in septic shock patients, whereas the levels of activated caspase-1 in AM B cells were lower compared with activated caspase-3. Moreover, in vitro experiments showed that Z-DEVD-FMK and VX-765 could alleviate the depletion of IM, AM, and RM B cells. The selective reduction of circulating B cell subsets in septic shock patients could be attributed to intrinsic and extrinsic apoptosis as well as pyroptosis.
参考来源
- Dong X, Tu H, Bai X, et al. INTRINSIC/EXTRINSIC APOPTOSIS AND PYROPTOSIS CONTRIBUTE TO THE SELECTIVE DEPLETION OF B CELL SUBSETS IN SEPTIC SHOCK PATIENTS. Shock. 2023. PMID: 37477437. doi:10.1097/SHK.0000000000002174
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。